Head to head
Equifax vs Verisk Analytics
Side-by-side on the measures that matter, with a plain-English read. Full detail: EFX · VRSK
EFX
Equifax
142.43-0.04%
1-year price shape — -39% over the period
Quant Rating E · 7/100
vs
VRSK
Verisk Analytics
168.68+2.11%
1-year price shape — -31% over the period
Quant Rating E · 11/100
1-year performance, rebased to 100
Verisk Analytics edges it on the scoreable measures. Verisk Analytics has the highest Quant Rating (11); Verisk Analytics has done best over the past year (-31%); Verisk Analytics earns the most per share.
| EFX | VRSK | |
|---|---|---|
| Snapshot | ||
| Sector | Consulting Services | -- |
| Last price | 142.43 | 168.68 |
| Change today | -0.04% | +2.11% |
| 1-year return | -39.5% | -30.8% |
| Market cap | $16.73B | $21.95B |
| 52-week range | 137.01 – 236.24 | 155.10 – 243.24 |
| Valuation | ||
| P/E (TTM) | 25.03 | 25.91 |
| P/E percentile, own 5-yr range | 2nd | 1st |
| P/B | 3.82 | -18.47 |
| Dividend yield | 1.49% | 1.13% |
| Profitability & growth | ||
| EPS (TTM) | 5.32 | 6.48 |
| Net profit (TTM) | $625.02M | $843.41M |
| Revenue (TTM) | $6.44B | $3.14B |
| Revenue growth (YoY) | +10.6% | +4.4% |
| Gross margin | 55.5% | 70.2% |
| Operating margin | 17.9% | 43.9% |
| Net margin | 10.7% | 28.2% |
| Free cash flow (TTM) | $1.11B | $1.24B |
| Ownership & sentiment | ||
| Institutional ownership | 103.2% | 100.7% |
| Insider activity (12mo) | 35 buy / 15 sell | 27 buy / 22 sell |
| Short interest (% of float) | 6.6% | 3.6% |
| Analyst consensus | 75% buy / 25% hold (20) | 54% buy / 46% hold (13) |
| Analyst price target | $210 (+47%) | $236 (+40%) |
| StockVane view | ||
| StockVane Quant Rating | E (7) | E (11) |
| Company | ||
| Employees | 15,000 | 8,000 |
| Founded | 1899 | 1971 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.